Affinage

Showing CNTRLCEP110 is a alias.

CNTRL

Centriolin · UniProt Q7Z7A1

Length
2325 aa
Mass
268.9 kDa
Annotated
2026-06-09
12 papers in source corpus 5 papers cited in narrative 5 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 4/5 claims corpus-supported (80%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

CNTRL (CEP110/centriolin) is a centrosome-associated coiled-coil protein required for centrosome maturation and microtubule-organizing center (MTOC) function (PMID:11956314). It localizes to a specific domain corresponding to the open end of the centrosome tube—the site of protein addition during maturation of a daughter into a mother centrosome—and antibody-mediated interference disrupts reformation of the tubular conformation of centrosomal proteins after division and impairs MTOC activity (PMID:11956314). Its C-terminal domain directly binds Hook2 at the centrosome; this interaction is needed to maintain proper distribution of centrosomal and pericentrosomal proteins and to support radial microtubule organization and microtubule regrowth (PMID:17140400). CNTRL function is required for proliferation and viability, as gene disruption in rhabdomyosarcoma cells causes cell cycle arrest and apoptosis (PMID:41370122). In oncogenesis, CNTRL contributes its four leucine zipper motifs to fusion proteins with FGFR1: the CEP110-FGFR1 fusion from t(8;9)(p12;q33) retains these oligomerization motifs and the FGFR1 catalytic domain, producing constitutive, ligand-independent tyrosine kinase activity and cytoplasmic mislocalization (PMID:10688839).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 2000 Medium

    Established CNTRL as a centrosomal coiled-coil protein whose leucine zipper motifs can drive oncogenic kinase activation when fused to FGFR1, defining the molecular basis of a leukemia-associated translocation.

    Evidence Molecular cloning, transient expression, kinase activity assay, and immunofluorescence of the CEP110-FGFR1 fusion from t(8;9)(p12;q33)

    PMID:10688839

    Open questions at the time
    • Endogenous CNTRL function not addressed
    • Oligomerization mechanism inferred from leucine zippers but not directly dissected
  2. 2002 High

    Defined where CNTRL acts on the centrosome and showed it is functionally required for MTOC activity, linking its position at the maturing open end of the centrosome tube to centrosome maturation.

    Evidence Immunofluorescence mapping with CEP250/c-Nap1, antibody microinjection into HeLa and PtK2 cells with MTOC readout

    PMID:11956314

    Open questions at the time
    • Molecular partners mediating maturation not identified here
    • Antibody microinjection does not pinpoint the affected protein domain
  3. 2006 Medium

    Identified a direct molecular partner (Hook2) bound by the CNTRL C-terminal domain, providing a mechanistic link between CNTRL and radial microtubule organization.

    Evidence Pulldown binding assay, co-localization, dominant-negative C-terminal overexpression, and nocodazole microtubule regrowth assay

    PMID:17140400

    Open questions at the time
    • Single lab; reciprocal in vivo validation limited
    • Stoichiometry and structural basis of the CNTRL-Hook2 interaction unresolved
  4. 2025 Medium

    Demonstrated that CNTRL is required for cancer cell proliferation and survival, extending its centrosomal role to a dependency in rhabdomyosarcoma.

    Evidence CRISPR/Cas9 gene disruption with viability and cell cycle analysis in CCL-136 rhabdomyosarcoma cells

    PMID:41370122

    Open questions at the time
    • Single cell line and single study
    • Mechanistic link between centrosomal defect and apoptosis not resolved
  5. 2025 Low

    Showed that alternative splicing at the CNTRL::FGFR1 breakpoint can still yield a kinase-domain-retaining fusion, broadening the structural variants capable of oncogenic activation.

    Evidence Targeted transcriptome sequencing, RT-PCR, and Sanger sequencing of a single case

    PMID:41266899

    Open questions at the time
    • Constitutive activation inferred from kinase-domain retention, not directly assayed
    • Single case report without functional validation

Open questions

Synthesis pass · forward-looking unresolved questions
  • How CNTRL coordinates Hook2 binding with centrosome maturation at the molecular level, and how its loss mechanistically triggers cell cycle arrest, remain unresolved.
  • No structural model of CNTRL or its complexes
  • Pathway connecting MTOC defect to apoptosis uncharacterized
  • Full interactome beyond Hook2 unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008092 cytoskeletal protein binding 1
Localization
GO:0005815 microtubule organizing center 2
Pathway
R-HSA-1640170 Cell Cycle 2 R-HSA-1643685 Disease 2
Partners

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2002 CEP110 (CNTRL) localizes to a specific domain of the centrosome corresponding to the open end of the centrosome tube, which is the site of protein addition during maturation of a daughter centrosome into a mother centrosome. Microinjection of anti-CEP110 antibodies into metaphase cells disrupted reformation of the tubular conformation of centrosomal proteins following cell division and impaired centrosome function as a microtubule organizing center (MTOC). Immunofluorescence mapping, co-localization with CEP250/c-Nap1, antibody microinjection into HeLa and PtK2 cells with functional MTOC readout Journal of cell science High 11956314
2000 CEP110 (CNTRL) is a centrosome-associated coiled-coil protein (994 amino acids) with four leucine zipper motifs. The CEP110-FGFR1 fusion protein arising from t(8;9)(p12;q33) retains the leucine zipper motifs of CEP110 and the catalytic domain of FGFR1, resulting in constitutive (ligand-independent) tyrosine kinase activity and cytoplasmic localization. Molecular cloning, transient expression, kinase activity assay, immunofluorescence localization of fusion protein Blood Medium 10688839
2006 Hook2 directly binds to the C-terminal domain of centriolin/CEP110 (CNTRL) at the centrosome. The C-terminal domain of centriolin/CEP110, when overexpressed, alters the distribution of endogenous hook2. Mislocalized hook2 perturbs centrosomal and pericentrosomal proteins, and interference with hook2 function (which depends on its interaction with CEP110) results in loss of radial microtubule organization and defective microtubule regrowth after nocodazole washout. Direct binding assay (pulldown), co-localization, dominant-negative overexpression of CEP110 C-terminal domain, microtubule regrowth assay after nocodazole treatment Traffic (Copenhagen, Denmark) Medium 17140400
2025 CRISPR/Cas9-mediated disruption of the centriolin/CEP110 gene (CNTRL) in rhabdomyosarcoma cells (CCL-136) leads to cell cycle arrest and apoptotic cell death, establishing a required role for CNTRL in rhabdomyosarcoma cell proliferation and viability. CRISPR/Cas9 gene disruption, cell viability assay, cell cycle analysis in rhabdomyosarcoma cell line Molecular biology of the cell Medium 41370122
2025 A novel splicing variant of CNTRL::FGFR1 fusion (involving an in-frame fusion between exon 38 of CNTRL and exon 11 of FGFR1) retains the kinase domain of FGFR1 and leads to its constitutive activation, demonstrating that alternative splicing at the fusion breakpoint can still produce an oncogenic, constitutively active kinase. Targeted transcriptome sequencing, RT-PCR, Sanger sequencing Journal of hematopathology Low 41266899

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 CEP110 and ninein are located in a specific domain of the centrosome associated with centrosome maturation. Journal of cell science 125 11956314
2000 FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood 122 10688839
2006 Hook2 localizes to the centrosome, binds directly to centriolin/CEP110 and contributes to centrosomal function. Traffic (Copenhagen, Denmark) 55 17140400
2004 NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder. Cancer research 51 15087377
2008 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality. Cancer genetics and cytogenetics 21 18295660
2015 Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1. PloS one 18 25803811
2007 Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature. Leukemia research 17 18096225
2017 Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement. The oncologist 11 28242791
2019 Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia. Pediatric blood & cancer 5 31250523
2015 [8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a patient]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 1 26418991
2025 A novel splicing variant of CNTRL::FGFR1 in myeloid/lymphoid neoplasm with eosinophilia and rearrangement of FGFR1. Journal of hematopathology 0 41266899
2025 Disruption of the centriolin/Cep110 gene (CNTRL) with CRISPR/Cas9 leads to cell cycle arrest and cell death of rhabdomyosarcoma cells in vitro. Molecular biology of the cell 0 41370122

Missed literature

Know a paper Affinage missed for CNTRL? Flag it for the maintainers and the community.

No submissions yet.